ClinicalTrials.Veeva

Menu

Effectiveness of a Intraoperative Blood Recovery System in Cardiovascular Surgery in Brazil

I

Instituto Materno Infantil Prof. Fernando Figueira

Status

Enrolling

Conditions

Blood Loss, Surgical
Cardiovascular Surgery

Treatments

Device: Use of a operative blood salvage system

Study type

Interventional

Funder types

Other

Identifiers

NCT06601582
IMIFernandoFigueira

Details and patient eligibility

About

Randomized trial to evaluate the effectiveness of a intra operative blood recovery system in reducing the need for allogeneic transfusion in cardiovascular surgeries using cardiopulmonary bypass

Full description

To evaluate the effectiveness of a intra operative blood recovery system in reducing the need for allogeneic transfusion in cardiovascular surgeries using cardiopulmonary bypass, a randomized clinical trial will be conducted. The study will be conducted at a teaching hospital, which is a reference for major cardiac surgeries and receives patients from the Brazilian Unified Health System (SUS). The patients will be randomly assigned to two groups: with and without the use of the system, and allocation concealment will be performed. Continuous variables will be analyzed through frequency distributions and appropriate descriptive measures (mean or median), while categorical variables will be presented through frequency distributions. For categorical variables, the confidence interval will be calculated, conventionally set at 95%. For continuous variables, the T-test will be used to measure differences, while for categorical variables, the McNemar statistical test will be used. For all analyses, a significance level of 5% will be used, and the data will be analyzed according to the intention-to-treat principle.

Enrollment

60 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • all patients undergoing CABG or Valve surgery singly.

Exclusion criteria

  • Emergency cardiac surgery;
  • Previous heart surgery;
  • End-stage chronic kidney disease;
  • Inability to receive a blood transfusion (refusal);
  • Anemia (hemoglobin less than 10g/dl);
  • Thrombocytopenia (platelet count less than 100,000/mm3);
  • Coagulopathy (RNI > 1.5);

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 2 patient groups

Intervention
Experimental group
Description:
Device: Use of a operative blood salvage system The surgical team will use a operative blood salvage system
Treatment:
Device: Use of a operative blood salvage system
No intervention
No Intervention group

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems